myasthenia gravis Flashcards
symptoms of MG
- extraocular muscles
- – ptosis
- pupils unaffected
— diplopia
Typically at the end of the day - ophthalmoplegia
BULBAR involvement - dysphagia, dysphonia, dysarthria, weak face and jaw
limb weakness
- proximal and symmetrical
neck weakness - neck flexion and extension
resp muscle weakness -SOB
distended neck veins and flushed face are likely to be caused by superior vena cava obstruction, which can be a complication of thymomas. Thymomas are associated with myasthenia gravis
complications of MG
resp failure
myasthenic crisis -
when the muscles that control breathing weaken to the point where individuals require a ventilator to help them breathe. It may be triggered by infection, stress, surgery, or an adverse reaction to medication.
drooling, weak neck, slack facial muscles
Ix for MG
- autoantibodies - AchR, MuSK, LRP4
- single fibre electromyography EMG : high sensitivity (92-100%)
- decrement in amplitude
- increased jitter using a single-fibre electrode - CT thorax to exclude THYMOMA
CK normal - tensilon test - IV edrophonium reduces muscle weakness temporarily - not commonly used any more due to the risk of cardiac arrhythmia
bloods - TFTs
spirometry - check vital capacity if below 1.5 litres requires transfer of the patient to ITU/HDU
what is myasthenic crisis
- respiratory failure os the most common presentation
- resp muscle weakness, inability to clear bronchial secretions and bronchospasm all contribute to respiratory failure
- pregnancy may precipitate a myasthenic crisis
Slack facial muscles Weak neck Drooling Nasal speech Generally weak Unsafe swallow
cholinergic crisis?
Looks similar to myasthenic crisis.
Excess of acetylcholinesterase inhibitors
excessive stimulation of striated muscle - flaccid paralysis
Respiratory failure
Miosis and the SLUDGE syndrome
(ie, salivation, sweating, lacrimation, urinary incontinence, diarrhea, GI upset and hypermotility, emesis) also may mark cholinergic crisis-not inevitably present
what is tensilon test
allows MG patient to move muscles normally
tensilon test CI when
Caution – asthma, MI, bradycardia
Cardiac monitoring
early management of MG
Supportive measures
Bedside spirometry
FVC
If falling rapidly or FVC< 20ml/kg review as may need ventilation
Blood gases ↑CO2 ↓O2 acidosis late manifestations of type II respiratory failure
therapeutic management fo MG
Anticholinesterase inhibitors-
- Pyridostigmine
Onset 30min; peak 60-120min; duration 3-6hr
- Neostigmine (ITU)
- Corticosteroids
Start low – high dose may paradoxically worsen symptoms - Azathioprine - Steroid sparing
- IV immunoglobulin
Acute decline or crisis – 60% will respond after 7-10 days
Plasmapheresis- removes AChR antibodies ->short-term improvement
Similar efficacy to IV Ig
what findings are elicited or seen in a MG patient during an examination
- Repeated blinking will exacerbate ptosis
- Prolonged upward gazing will exacerbate diplopia on further eye movement testing
- Repeated abduction of one arm 20 times will result in unilateral weakness when comparing both sides
- thymectomy scar
- test for forced vital capacity
when checking the eye ask them to count fingers
ask initially if they have double vision
if yes then ask if it gets worse with any movement
if no ask if they do get any DV at any point
swallowing
does anyone not understand them
chicken arms
Risk factors of a MG patient
DVT
swallowing test so NBM until then if necessary do feeding tube
Resp test FVC if that is not possible then do single breath test
Mx of myasthenic crisis
non-invasive ventilation with BiPAP or full intubation and ventilation.
plasmapheresis
IVIG
what is lamber eaton syndrome
Sx
Ix
Mx
antibodeis attacking NMJ
weakness of the proximal limb muscles esp lower limbs
no ocular and other cranial nerves involvement
gets better after exercise
Ix EMG
ass w small cell carcinoma
Mx
guanethidine hydrochloride
4-aminopyridine
IVIG and plasmapharesis
where is botulim toxin used clinically
cervical dystonia
blepharospasm
sever limb spasticity following stroke or MS
associations of MG
- thymomas in 15%
- autoimmune disorders: pernicious anaemia, autoimmune thyroid disorders, rheumatoid, SLE
- thymic hyperplasia in 50-70%